Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study

Background Experimental data suggest that catecholamine hormones are involved in stimulating the aggressiveness of ovarian cancer, but few population-based studies have examined this association. We therefore conducted a population-based cohort study to examine whether s-blockers affect mortality following ovarian cancer diagnosis.